Maximum quantity allowed is 999
Please select the quantity
CAS RN: 27314-97-2 | Product Number: T3823
Tirapazamine
Purity: >98.0%(HPLC)
Synonyms:
- SR 259075
- 3-Aminobenzo[e][1,2,4]triazine 1,4-Dioxide
Product Documents:
* Please contact our distributors or
TCI
to order our products. The above prices do not include freight cost, customs, and other charges to the destination.
* The storage conditions are subject to change without notice.
Product Number | T3823 |
Purity / Analysis Method | >98.0%(HPLC) |
Molecular Formula / Molecular Weight | C__7H__6N__4O__2 = 178.15 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Refrigerated (0-10°C) |
Condition to Avoid | Heat Sensitive |
Packaging and Container | 250MG-Glass Bottle with Plastic Insert (View image), 50MG-Glass Bottle with Plastic Insert (View image) |
CAS RN | 27314-97-2 |
Reaxys Registry Number | 179322 |
PubChem Substance ID | 468592963 |
Merck Index (14) | 9461 |
MDL Number | MFCD00132954 |
Specifications
Appearance | Orange to Red powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Properties (reference)
Melting Point | 230 °C(dec.) |
Maximum Absorption Wavelength | 457(H2O) nm |
GHS
Pictogram | |
Signal Word | Warning |
Hazard Statements | H315 : Causes skin irritation. H319 : Causes serious eye irritation. |
Precautionary Statements | P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ eye protection/ face protection. P302 + P352 : IF ON SKIN: Wash with plenty of water. P337 + P313 : If eye irritation persists: Get medical advice/ attention. P305 + P351 + P338 : IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P362 + P364 : Take off contaminated clothing and wash it before reuse. P332 + P313 : If skin irritation occurs: Get medical advice/ attention. |
Related Laws:
RTECS# | DM0671500 |
Transport Information:
H.S.code* | 2933.99-000 |
Application
Tirapazamine: A Hypoxia-Activated Antitumor Agent
Tirapazamine, also known as SR-4233, is a hypoxia-activated antitumor agent.1-3) It is converted to the reactive one-electron reduction product (radical anion) under hypoxic condition. The radical product abstracts a proton from DNA to form DNA radicals, largely at C4’ on the ribose ring. Tirapazamine can also oxidized such DNA radicals to cytotoxic DNA strand breaks.4) Recently, the antitumor effects of tirapazamine in combination with cisplatin [D3371]3), and tirapazamine prodrugs5) have been studied. (The product is for research purpose only.)
References
- 1) SR-4233: a new bioreductive agent with high selective toxicity for hypoxic mammalian cells
- 2) SR 4233 (tirapazamine): a new anticancer drug exploiting hypoxia in solid tumours (a review)
- 3) The hypoxic cell: a target for selective cancer therapy-eighteenth Bruce F. Cain memorial award lecture
- 4) Selective Potentiation of the Hypoxic Cytotoxicity of Tirapazamine by Its 1-N-Oxide Metabolite SR 4317
- 5) Q6, a novel hypoxia-targeted drug, regulates hypoxia-inducible factor signaling via an autophagy-dependent mechanism in hepatocellular carcinoma
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.